~~<i id='D4DD311CE5'><strike id='D4DD311CE5'><tt id='D4DD311CE5'><pre id='D4DD311CE5'></pre></tt></strike></i>~~

Home» explore» fashion

fashion

author：Wikipedia 2025-09-10 08:37:33 Page View：347

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： American taxpayers paid $1.8 trillion in health care costs in 2022
Next article： As demand for Covid shots wanes, Moderna seeks its next success

explore

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

FILE-HandgunsaredisplayedatagunshoponJune,23,2022,inHonolulu.ThreeHawaiiresidentschallengingthestate

Malaria cases in Florida and Texas: Here’s what you need to know

MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

8:47PresidentJoeBidenspeaksabouttheSupremeCourt'sdecisiontostrikedownrace-consciousstudentadmissions